Learn about unique career paths in pharmacy. APhA CEO Thomas Menighan discusses his personal journey in pharmacy and provides insight into non-traditional roles for pharmacists highlighted in the new, free webinar series Careers Beyond the Pharmacy Counter.
Although women comprise a majority of the global health workforce, they are under-represented at the decision-making level of global policy and governance. This workforce pipeline challenge was a focus of recent remarks by the President of Mauritius, Her Excellency Ameenah Gurib-Fakim, during an event hosted by USP’s CePAT in Ghana to celebrate African women leaders in pharmacuetical regulatory affairs.
Two students from the University of Kentucky College of Pharmacy and the University of Maryland Baltimore School of Pharmacy, report on their summer internship at USP sharing their experiences, lessons learned and hopes for a bright future career impacting public health.
Medicines quality is at the center of CePAT’s work. Equipped with a new lab and expanded capabilities, CePAT is now tackling barriers to quality and hopes to change the odds that African’s will receive quality-assured medicines.
New USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings provides consistent standards for the handling of hazardous drugs in healthcare settings to help minimize exposure to healthcare workers, avoid unintended and repeated exposures, and reduce the potential for adverse consequences.
Poor quality medicines are the source of an alarming, but often overlooked global health crisis. A report from the International Policy Network estimates that 700,000 people die every year from fake anti-malarial and tuberculosis drugs alone.
Like most African countries, the challenges facing the Zambian pharmaceutical industry are vast. But under the leadership of Ms. Esnart Mwape, Director General of the Zambia Medicines Regulatory Authority, challenges such as counterfeit drugs are being addressed, as the Authority respositions itself to take charge of the market. Read more.
In Liberia, sellers of poor-quality medicines are capitalizing on public fears about Ebola. Learn what the Liberia Medicines and Health Products Regulatory Authority is doing about it and how the Promoting the Quality of Medicines Program--a collaborative effort between USAID and USP--is playing a role.